Sat 11 Oct 2008 | 4:13 EDT
You are here: Home > News > Article
Home
Business & Finance
News
U.S.
Politics
International
Technology
Entertainment
Sports
Lifestyle
Oddly Enough
Environment
Health
Science
Special Coverage
Video
Pictures
You Witness
Blogs
Reader Feedback
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
You Witness News
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

DUSA Pharma Levulan Kerastick receives marketing approval in Korea

Wed Oct 3, 2007 6:33am EDT
 
Email | Print | | Reprints | Single Page
[-] Text [+]
Co announces that the Korea Food and Drug Administration has approved Levulan Kerastick for Photodynamic Therapy for the treatment of actinic keratoses through its marketing partner Daewoong Pharmaceutical and its affiliate, DNC Daewoong Derma & Plastic Surgery Network. Having received approval, market launch is expected in the first quarter of 2008.

 

Also On Reuters

Featured Broker sponsored link

Editor's Choice

  • Pictures
  • Video
  • Articles
Photo

A selection of our best photos from the past 24 hours.  View Slideshow 

Most Popular on Reuters

  • Articles
  • Video
  • Recommended

Reuters Oddly Enough

Funny, quirky, strange-but-true stories from around the world.
Photo
Watch the videos
Read the stories
Get the daily newsletter
Check out the blog